211 related articles for article (PubMed ID: 22160905)
1. Recombinant protein production in the eukaryotic protozoan parasite Leishmania tarentolae: a review.
Niimi T
Methods Mol Biol; 2012; 824():307-15. PubMed ID: 22160905
[TBL] [Abstract][Full Text] [Related]
2. Expression of multisubunit proteins in Leishmania tarentolae.
Sugino M; Niimi T
Methods Mol Biol; 2012; 824():317-25. PubMed ID: 22160906
[TBL] [Abstract][Full Text] [Related]
3. Expression of human tissue plasminogen activator in the trypanosomatid protozoan Leishmania tarentolae.
Soleimani M; Mahboudi F; Davoudi N; Amanzadeh A; Azizi M; Adeli A; Rastegar H; Barkhordari F; Mohajer-Maghari B
Biotechnol Appl Biochem; 2007 Sep; 48(Pt 1):55-61. PubMed ID: 17371294
[TBL] [Abstract][Full Text] [Related]
4. Leishmania tarentolae for the Production of Multi-subunit Complexes.
Niimi T
Adv Exp Med Biol; 2016; 896():155-65. PubMed ID: 27165324
[TBL] [Abstract][Full Text] [Related]
5. Recombinant protein expression in Leishmania tarentolae.
Basile G; Peticca M
Mol Biotechnol; 2009 Nov; 43(3):273-8. PubMed ID: 19779853
[TBL] [Abstract][Full Text] [Related]
6. Development of an inducible protein expression system based on the protozoan host Leishmania tarentolae.
Kushnir S; Gase K; Breitling R; Alexandrov K
Protein Expr Purif; 2005 Jul; 42(1):37-46. PubMed ID: 15939291
[TBL] [Abstract][Full Text] [Related]
7. Artificial linear episome-based protein expression system for protozoon Leishmania tarentolae.
Kushnir S; Cirstea IC; Basiliya L; Lupilova N; Breitling R; Alexandrov K
Mol Biochem Parasitol; 2011 Apr; 176(2):69-79. PubMed ID: 21167214
[TBL] [Abstract][Full Text] [Related]
8. Isotopic labeling of recombinant proteins expressed in the protozoan host Leishmania tarentolae.
Niculae A; Bayer P; Cirstea I; Bergbrede T; Pietrucha R; Gruen M; Breitling R; Alexandrov K
Protein Expr Purif; 2006 Aug; 48(2):167-72. PubMed ID: 16740394
[TBL] [Abstract][Full Text] [Related]
9. Potential application of Leishmania tarentolae as an alternative platform for antibody expression.
Lai JY; Klatt S; Lim TS
Crit Rev Biotechnol; 2019 May; 39(3):380-394. PubMed ID: 30720351
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of recombinant human tissue plasminogen activator in Leishmania tarentolae.
Hemayatkar M; Mahboudi F; Majidzadeh-A K; Davami F; Vaziri B; Barkhordari F; Adeli A; Mahdian R; Davoudi N
Biotechnol J; 2010 Nov; 5(11):1198-206. PubMed ID: 21058320
[TBL] [Abstract][Full Text] [Related]
11. The production of recombinant human laminin-332 in a Leishmania tarentolae expression system.
Phan HP; Sugino M; Niimi T
Protein Expr Purif; 2009 Nov; 68(1):79-84. PubMed ID: 19607924
[TBL] [Abstract][Full Text] [Related]
12. Non-pathogenic trypanosomatid protozoa as a platform for protein research and production.
Breitling R; Klingner S; Callewaert N; Pietrucha R; Geyer A; Ehrlich G; Hartung R; Müller A; Contreras R; Beverley SM; Alexandrov K
Protein Expr Purif; 2002 Jul; 25(2):209-18. PubMed ID: 12135552
[TBL] [Abstract][Full Text] [Related]
13. Exploiting Leishmania tarentolae cell-free extracts for the synthesis of human solute carriers.
Ruehrer S; Michel H
Mol Membr Biol; 2013 Jul; 30(4):288-302. PubMed ID: 23802133
[TBL] [Abstract][Full Text] [Related]
14. Humanizing glycosylation pathways in eukaryotic expression systems.
Khan AH; Bayat H; Rajabibazl M; Sabri S; Rahimpour A
World J Microbiol Biotechnol; 2017 Jan; 33(1):4. PubMed ID: 27837408
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the growth behavior of Leishmania tarentolae: a new expression system for recombinant proteins.
Fritsche C; Sitz M; Weiland N; Breitling R; Pohl HD
J Basic Microbiol; 2007 Oct; 47(5):384-93. PubMed ID: 17910102
[TBL] [Abstract][Full Text] [Related]
16. Leishmania tarentolae: Taxonomic classification and its application as a promising biotechnological expression host.
Klatt S; Simpson L; Maslov DA; Konthur Z
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007424. PubMed ID: 31344033
[TBL] [Abstract][Full Text] [Related]
17. Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae.
Azizi H; Hassani K; Taslimi Y; Najafabadi HS; Papadopoulou B; Rafati S
Parasitology; 2009 Jun; 136(7):723-35. PubMed ID: 19416551
[TBL] [Abstract][Full Text] [Related]
18. Development of a defined medium for heterologous expression in Leishmania tarentolae.
Fritsche C; Sitz M; Wolf M; Pohl HD
J Basic Microbiol; 2008 Dec; 48(6):488-95. PubMed ID: 18759244
[TBL] [Abstract][Full Text] [Related]
19. Production of glycosylated soluble amyloid precursor protein alpha (sAPPalpha) in Leishmania tarentolae.
Klatt S; Rohe M; Alagesan K; Kolarich D; Konthur Z; Hartl D
J Proteome Res; 2013 Jan; 12(1):396-403. PubMed ID: 23214446
[TBL] [Abstract][Full Text] [Related]
20. Production of Recombinant Trypanosoma cruzi Antigens in Leishmania tarentolae.
Ferrer MJ; Wehrendt DP; Bonilla M; Comini MA; Tellez-Iñón MT; Potenza M
Methods Mol Biol; 2019; 1955():105-118. PubMed ID: 30868522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
